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Objectives:Artemisinin andartemisinin semi-synthetic derivatives (collectively knownasendoperoxides) arefirst-
line antimalarials for the treatment of uncomplicated and severe malaria. Endoperoxides display very fast killing
rates andare generally recalcitrant to parasite resistancedevelopment. These key pharmacodynamic features are
a result of a complex mechanism of action, the details of which lack consensus. Here, we report on the primary
physiological events leading to parasite death.
Methods: Parasitemitochondrial (DCm) andplasmamembrane (DCp) electrochemical potentialsweremeasured
using real-time single-cell imaging following exposure to pharmacologically relevant concentrations of endoperox-
ides (artemisinin, dihydroartemisinin, artesunate and the synthetic tetraoxane RKA182). In addition,mitochondrial
electron transport chain components NADH:quinone oxidoreductase (alternative complex I), bc1 (complex III) and
cytochrome oxidase (complex IV) were investigated to determine their functional sensitivity to the various endo-
peroxides.
Results: Parasite exposure to endoperoxides resulted in rapid depolarization of parasiteDCmandDCp. The rate of
depolarization was decreased in the presence of a reactive oxygen species (ROS) scavenger and Fe3+ chelators.
Depolarization of DCm by endoperoxides is not believed to be through the inhibition of mitochondrial electron
transport chain components, owing to the lack of significant inhibition when assayed directly.
Conclusions: The depolarization of DCm and DCp is shown to be mediated via the generation of ROS that are
initiated by iron bioactivation of endoperoxides and/or catalysed by iron-dependent oxidative stress. These data
are discussed in the context of current hypotheses concerning the mode of action of endoperoxides.
Keywords: Plasmodium, mitochondria, iron, haem, lipid peroxidation, free radicals, oxidative damage
Introduction
Artemisinin is a tetracyclic 1,2,4-trioxane containing an endoper-
oxide bridge (C-O-O-C; Figure 1), the key pharmacophore of the
drug.1 To improve the solubility and pharmacological activity of ar-
temisinin, a first series of semi-synthetic compoundswere synthe-
sized with a similar backbone but with modifications at the C10
position, generating hemi-acetal, ether or ester derivatives such
as dihydroartemisinin, artemether and artesunate (Figure 1). Arte-
misinins possess potent antimalarial activity and theWHO recom-
mends the use of artemisinin combination therapy for first-line
therapy of Plasmodium falciparum malaria worldwide. Based on
the structure of the endoperoxide bridge, extensive studies have
been devoted to the synthesis of fully synthetic endoperoxides,
someofwhicharecurrently in clinicalandpre-clinicaldevelopment
(e.g.OZ439, anozonidedesigned toprovidea single-doseoral anti-
malarial cure in humans, and the tetraoxane RKA182; Figure 1).2,3
The mechanism(s) of activation and subsequent biological
target(s) of endoperoxides continue to be debated.4 The antimal-
arial activity of the artemisinins and related bioactive endoperox-
ides is believed to be mediated by activation of the endoperoxide
bridge. Located in the core of the structure, its cleavage generates
short-lived cytotoxic oxyradicals in the presence of haem iron or
free iron Fe2+.5,6 From this premise of ‘endoperoxide bioactivation’,
twodifferentmechanismshavebeenproposed. Thefirst, proposed
by the Posner laboratory using 18O-labelled trioxane analogues,
hypothesizes that the oxygen-centred radicals produced are re-
arranged tomore stable carbon-centred radicals.7,8In this ‘reductive
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scission’ model, ferrous iron binds to either O1 or O2 cleaving
the endoperoxide bond and generating oxyradical intermediates
(Figure S1, available as Supplementary data at JAC Online). Both
radicals subsequently rearrange to primary or secondary carbon-
centred radicals via either b-scission or a [1,5]-H shift. In support
of this hypothesis, evidence of the formation of these carbon-
centred radical intermediates has been provided using electron
paramagnetic resonance spin-trapping techniques.9–11 It has
been proposed that these C-centred radicals are capable of haem
and/or protein alkylation; whilst Meunier and coworkers12 have pro-
vided evidence for haem alkylation, there are only a few reports of
model studies on protein alkylation involving reactions with ferrous
salts in the presence of cysteine (iron–sulphur chelates).13
In the secondmodel, it is hypothesized that iron acts as a Lewis
acid to facilitate ionic activation of antimalarial trioxanes generat-
ing downstream reactive oxygen species (ROS; Figure S1, available
as Supplementary data at JAC Online).14,15 The ring opening
involves heterolytic cleavage of the endoperoxide bridge followed
by interaction with water generating an open, unsaturated hydro-
peroxide, capable of direct oxidation of protein residues. Fenton
degradation of the oxygen-centred radical intermediate can
provide hydroxyl radicals (HO·) highly reactive against amino
acids, lipids or nucleic acids.
An alternative pathway of artemisinin bioactivation has been
suggested via electron transport chain (ETC) components causing
downstream ROS production and membrane depolarization in iso-
lated Plasmodiummitochondria.16,17 Analogous to this hypothesis,
a further hypothesis known as the ‘cofactor model’ proposes that
endoperoxides are reduced by redox-active flavoenzymes, resulting
in the perturbation of redox homeostasis coupled with the gener-
ation of ROS (Figure S1, available as Supplementary data at JAC
Online).18 The cofactor model of artemisinin activation, however,
is not restricted to mitochondrial flavoenzymes but rather impli-
catescytosolicflavoenzymesandalsorejectsthedirectrequirement
for either Fe2+ and/or non-haem iron activation.
Formodels involving iron-based activation, the origin of the iron
available for bioactivation is also a point of debate. There is experi-
mental evidence for the involvement of both haemandnon-haem
iron in the bioactivation.19,20
The involvementof haem in theactivation of endoperoxide com-
pounds was first proposed following isolation of haem–artemisinin
adduct in P. falciparum cultures.6 By using [14C]artemisinin, Maeno
et al.21 showed its accumulation in the digestive food vacuole
where haemoglobin degradation leads to the release of soluble
haem. More recently, inhibition of haemoglobin digestion by the
genetic deletion of cysteine protease falcipain-2 was shown to sig-
nificantly attenuate in vitro endoperoxide-mediated parasite kill.22
Haem has been observed to enhance the oxidizing effects of endo-
peroxide drugs.23 As noted above, the reaction between haem and
artemisinin has been confirmed in vitro and in vivo.12,24,25 In add-
ition, it has been proposed that haem is the primary activator of ar-
temisinin, reactingwith itmoreefficiently thanother iron-containing
molecules (Fe2+, haemin or haemoglobin).26 It has also been
reported that antimalarial trioxanes accumulated into the food
vacuole are activated by neutral lipid-associated haem and induce
oxidative membrane damage.27,28
However,usingradio-orfluorescent-labelledartemisininsandmi-
croscopy, two studies contest the accumulation of endoperoxide
drugs in the food vacuole and their possible interaction with
haem.29,30Additionally,Haynesetal.31,32haveproposedthatartemi-
sinins do not inhibit haemozoin formation and cannot react with
haem according to conventional chemistry models. Several studies
have shown that iron chelation, selective for non-haem iron, antago-
nizes the accumulation and antimalarial activity of endoperoxide
antimalarials in vitroand canprevent their toxic effects inmice.5,30,33
Onceactivated,endoperoxideantimalarialshavebeenreported
to disrupt a number of parasite functions and enzymes, including
the haem detoxification pathway,23 the translationally controlled
tumour protein (PfTCTP),34 the sarco/endoplasmic reticulum
membrane calcium PfATPase630 and the parasite mitochondrion.
Specific targeting of parasite mitochondria by endoperoxides was
reported initially basedonmorphological changes tomitochondria
following exposure to artemether.20,35,36 Zhao et al.37 reported a
specific inhibitory effect by artemether against Plasmodium cyto-
chrome c oxidase (complex IV) that was later also reported by
Krungkrai et al.38 based on measurements of O2 consumption.
Liet al.16 hypothesizeda role for parasitemitochondria, specifically
the type II NADH:quinone oxidoreductase (PfNDH2),39,40 by acting
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Artemisinin O 7.5 + 0.2
Dihydroartemisinin OH 3.48 + 0.60
Artesunate OCO(CH2)2CO2NA 1.60 + 0.40
Artemether OCH3 4.46 + 0.75
Deoxyartemisinin >10 000
Tetraoxane (RKA182) 1.30 + 0.61
R In vitro IC50 (nM)
O
Figure 1. Chemical structures of endoperoxides, their corresponding P. falciparum growth inhibition values. Chemical structures of (a) artemisinin and its
semi-synthetic derivatives, (b) deoxyartemisinin and (c) the synthetic 1,2,4,5-tetraoxane drug-development candidate RKA182 used in this study. The
endoperoxide bridge is highlighted in grey. (d) P. falciparum growth inhibition IC50 values of endoperoxide antimalarials. Values are the mean+SEM of
results from three independent experiments.
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both as a target and as an activator of endoperoxides via electron
donation by the ETC. Conflicting data have since emerged, with
Crespo et al.41 only observingmitochondrial dysfunction (as deter-
mined by rhodamine 123 fluorescence) upon exposure to artemi-
sinin after 8 h but not after 4 h, interpreting this as a downstream
effect rather than an initiator of killing. Conversely, Wang et al.17
reported depolarization of the membrane potential of isolated
parasite mitochondria by artemisinin following 2 h of incubation.
Studies of artemisinin toxicity in human cells indicate that respir-
ing mitochondria play an essential role in endoperoxide-induced
cytotoxicity via the generation of ROS; however, using HeLa r0
cells, which are devoid of a functioning ETC, it was demonstrated
that the ETC does not have any role in the reductive activation of
the endoperoxide to cytotoxic carbon-centred radicals.42
We have previously described the use of a real-time single-cell
imaging method for monitoring malaria parasite mitochondrial
(DCm) and plasma membrane potential (DCp)
43,44 and reported
malaria parasite ETC activities including PfNDH2.40,45 Using these
approaches, we have re-examined the effect of endoperoxides
on parasite bioenergetic functions and discuss our data in the
context of the current hypotheses.
Materials and methods
Parasites, culture and drug sensitivity testing
P. falciparum (3D7 strain) cultures consisted of a 2% (v/v) suspension of O+
erythrocytes in RPMI1640medium (R8758, glutamine andNaHCO3) supple-
mented with 10% pooled human AB+ serum, 25 mM HEPES (pH 7.4) and
20 mM gentamicin sulphate.46 Cultures were grown under a gaseous head-
space of (in v/v) 4% O2 and 3% CO2 in N2 at 378C. Parasite growth was syn-
chronized by treatment with sorbitol.47 Drug susceptibilities were
determined with an inoculum size of 0.5% parasitaemia (ring stage) and
1% haematocrit and were assessed by the measurement of fluorescence
after the addition of SYBRGreen I asdescribedpreviously.48Drug50% inhibi-
tory concentration (IC50) values were calculated from the log of the dose–
response relationship, as fitted with Grafit software (Erithacus Software,
Horley, UK). Drug stock solutions (1–10 mM) were prepared in DMSO. The
results are given as the means of at least three separate experiments.
Preparation of P. falciparum cell-free extracts
Free parasites were prepared from aliquots of infected erythrocytes
(8×109 cells/mL) by adding 5 volumes of 0.15% (w/v) saponin in
phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 1.76 mM K2HPO4,
8.0 mM Na2HPO4 and 5.5 mM D-glucose, pH 7.4) for 5 min, followed by
threewashesbycentrifugationand resuspension inHEPES (25 mM)-buffered
RPMI containing a protease inhibitor cocktail (Complete Mini; Roche, Mann-
heim, Germany). Cell extract was prepared by repeated freeze–thawing in
liquid N2, followed by disruption with a sonicating probe.
Preparation of decylubiquinol
Theartificialquinolelectrondonorwaspreparedbasedonapreviouslydescribed
method.49 Briefly, 2,3-dimethoxy-5-methyl-n-decyl-1,4-benzoquinone (decy-
lubiquinone), an analogue of ubiquinone (Sigma, St Louis, MO, USA),wasdis-
solved (10 mg) in 400 mL of nitrogen-saturated hexane. An equal volume of
aqueous 1.15 M sodium dithionite was added and the mixture shaken
vigorously until colourless. The upper, organic phase was collected and
the decylubiquinol recovered by evaporating off the hexane under N2. The
decylubiquinol was dissolved in 100 mL of 96% ethanol (acidified with
10 mM HCl) and stored in aliquots at 2808C. Decylubiquinol concentration
was determined spectrophotometrically from absolute spectra, using
1288–320¼4.14 mM21 cm21.
Measurement of bc1 protein and complex IV activities
Decylubiquinol:cytochromecoxidoreductase (bc1protein) andcytochrome
c oxidase (complex IV) activity were assayed in a Cary 4000 spectropho-
tometer (Varian Inc., USA). The bc1 reaction buffer consisted of 50 mM po-
tassiumphosphate (pH7.5), 2 mMEDTA,10 mMKCN(1 Mstock solution,pH
adjusted to 7.5) and 30 mMhorse heart cytochrome c (oxidized) (Sigma).49
The complex IV mixture is composed of 50 mM potassium phosphate (pH
7.5), 2 mM EDTA and 5 mM antimycin. Inhibitors were added prior to the
additionofsubstrate.The reactionvolumewas700 mLandassayswereper-
formed at room temperature. P. falciparum bc1 and complex IV were
assayed fromcell-free P. falciparum extract at a total protein concentration
of 30–60 mg/mL. Cytochrome c reductase (bc1) and oxidase (complex IV)
activities were initiated, respectively, by the addition of 50 mMdecylubiqui-
nol (dQH2)and30 mMequinecytochromec (reduced). Thehorseheartcyto-
chrome c was reduced by sodium dithionite and then passed through a
PD-10 desalting column (Pharmacia, Piscataway, NJ, USA). Activities were
measured by monitoring the cytochrome c (reduced) concentration at
550–542 nm (1550–542¼18.1 mM21 cm21).
Measurement of PfNDH2 activity
PfNDH2 enzyme activity was determined based on a modification of the
NADH:quinoneoxidoreductaseassaypreviouslydescribed.50 Enzymeactiv-
ity was measured in a buffered solution (final volume 0.7 mL) containing
50 mM potassium phosphate (pH 7.5), 2 mM EDTA, 10 mM KCN and
50 mM coenzyme Q1 at room temperature. Recombinant PfNDH2 enzyme
was added as an Escherichia coli crude membrane preparation at a total
protein concentration of between 10 and 20 mg/mL.40 Inhibitors were
added before initiation of the reaction by addition of 200 mM NADH.
PfNDH2 activity was measured spectrophotometrically by monitoring the
decrease of NADH concentration at 340 nm (1340¼6.22 mM21 cm21)
and Q1 concentration at 283 nm (1283¼8.1 mM21 cm21).
Real-time single-cell monitoring of membrane potential
The rhodamine derivative tetramethyl rhodamine ethyl ester (TMRE) was
used tomonitor themembrane potential of the cytoplasm andmitochon-
dria from malaria-infected red blood cells. TMRE is cationic and reversibly
Table 1. Inhibitory profiles of endoperoxide compounds for three major
components of the ETC of P. falciparum (3D7 strain)
Inhibitor
Percentage inhibition
PfNDH2 bc1 (complex III) complex IV
Artemisinin (1 mM) 17.1+4.2 3.2+3.7 18.4+4.3
Tetraoxane (1 mM) 12.3+4.9 23.2+4.2 19.1+2.0
Dihydroartemisinin (1 mM) 5.0+4.3 6.7+4.1 21.1+7.9
Artesunate (1 mM) 3.7+2.9 2.3+0.4 21.1+3.9
Artemether (1 mM) 4.1+3.3 1.8+1.9 23.0+2.0
HDQ (100 nM) 88.1+0.5 ND ND
Atovaquone (50 nM) ND 89.0+1.0 ND
Cyanide (15 mM) ND ND 100+0.0
Specific inhibitors of PfNDH2 [1-hydroxy-2-dodecyl-4(1H)quinolone; HDQ],
bc1 protein (atovaquone) and complex IV (cyanide) were used as positive
controls. Direct activity assays were performed on recombinant PfNDH2
enzymes, whereas bc1 protein and complex IV were assayed with
cell-free parasite extracts.
Inhibitor concentrations used are indicated in brackets.
Valuesaremeans+SEM;n¼3independentexperiments. ND,notdetermined.
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accumulates inside energizedmembranes according to theNernst equation.
For the experiment, suspensions (1%) of infected erythrocytes in HEPES-
bufferedRPMImedium(noserum)were loadedwith250 nMTMRE (Molecu-
lar Probes, Eugene, OR, USA) for 10 min at 378C. For imaging, malaria
parasite-infected erythrocytes were immobilized using polylysine-coated
coverslips in a Bioptechs FCS2 perfusion chamber (Bioptechs, Butler, PA,
USA) and maintained at 378C in growth medium (no serum). Inhibitors
were added to the perfusate and the membrane potential-dependent
fluorescence responses were monitored in real time. During all manipula-
tions, the concentration of TMRE in the perfusate was kept at 250 nM. The
fluorescence signals frommalaria-infected erythrocytes were collected on a
Zeiss Pascal confocal laser scanningmicroscope through a Plan-Apochromat
63×1.2numericalaperturewaterobjective.ExcitationofTMREwasperformed
using the HeNe laser line (543 nm). Emitted light was collected through a
560 nmlong-passfilter froma543 nmdichroicmirror. Photobleaching (the ir-
reversibledamageofTMREproducinga lessfluorescentspecies)wasassessed
by continuous exposure (5 min) of loaded cells to laser illumination. For each
experiment, the laser illumination and microscope settings that gave
minimal reduction in signal were used. Data capture and extraction were
carried out with Zeiss Pascal software and plot design was performed with
Kaleidagraph (Synergy Software, Reading, PA, USA).
Results
Endoperoxides have a minimal inhibitory effect on the
major mitochondrial respiratory chain components
As described, there is conflicting evidence on the role of the parasite
ETC in the activation and/or resultantmitochondrial dysfunction fol-
lowing the exposure of parasites to endoperoxides. To determine
whether there is a direct inhibitory effect of endoperoxides on ETC
components, activities from three of the main ETC enzymes,
PfNDH2,bc1 complexandcytochrome coxidase,weremeasureddir-
ectly in the presence of a number of endoperoxides. As described in
the Materials and methods section, the bc1 complex (complex III)
and cytochrome c oxidase (complex IV) were measured directly
fromparasitecell-freeextracts,whilstPfNDH2activitywasmeasured
frommembrane preparations of a heterologous expression system
described previously.40 No or relatively weak (20%) inhibition of
the individual respiratorycomponentswasobserved forall theendo-
peroxides tested at comparatively high fixed doses (1 mM final con-
centration; Table 1). Positive controls using selective inhibitors of
the individual respiratory components were consistent with previ-
ously reported inhibitory values (Table 1).
Endoperoxides collapse membrane potential-dependent
accumulation of TMRE in P. falciparum-infected
erythrocytes
To determine the effect of endoperoxides onmembrane potential,
a real-time single-cell imaging approach was used. The measure-
ment is based on the accumulation of the cationic fluorescence
probe TMRE according to the Nernst equation. Due to dynamic
fluorescencemeasurements, the probe is subject to photobleach-
ing. To minimize this, several parameters of the confocal laser
scanning microscope (laser power, scan speed, pinhole diameter,
number of scan sweeps and degree of magnification) were
optimized before recording each experiment. Upon addition of
TMRE to P. falciparum-infected erythrocytes, a strong fluorescence
signal was observed from the whole cytosol (except the food
vacuole), corresponding to theadditionofplasmaandmitochondrial
membrane potential. For all assays, the fluorescence dynamic
range was set up so that untreated TMRE-loaded cells were
regarded as having complete fluorescence (100%), whereas the
baseline (0%) was set by the addition of 10 mM H+ ionophore car-
bonyl cyanide p-(trifluoromethyl)phenylhydrazone (FCCP).
The endoperoxide compounds used in this study were shown to
inhibit parasite growth in the low nanomolar range, consistent with
previousstudies (Figure1).Additionof endoperoxides to trophozoite-
stage parasites (100 nM) resulted in a 55%–60% reduction of
total membrane potential-dependent fluorescence within ,3 min
(Figure 2c–f). Using the same conditions, atovaquone, the selective
bc1 complex inhibitor, decreased the total membrane potential-
dependentfluorescenceby30%(Figure2a), consistentwithprevious
observations of themitochondrial contribution to fluorescence.43 In
contrast, additionofdeoxyartemisinin,which lacks theendoperoxide
bridge (Figure 1), resulted in the minimal loss of membrane
potential-dependent fluorescence, consistentwith its poor antimal-
arial activity (Figure 2b).
Although these experiments demonstrate for the first time the
rapid depolarization of membrane potential upon exposure to
endoperoxides, since there is a contribution from both plasma
(DCp) andmitochondrialmembrane (DCm) potentials to TMREac-
cumulation, further experiments were performed tomeasureDCp
and DCm independently.
Depolarization of the mitochondrial membrane potential
by endoperoxides
To evaluate the impact of endoperoxides on DCm, cells were pre-
treated with concanamycin A, a V-type H+-ATPase inhibitor. Upon
addition of concanamycin A (200 nM), the fluorescence intensity
from the cytosol decreases 70%–80%,43 leaving a local and
strong signal originating from theparasitemitochondrion, as demon-
strated in Figure3(b). TomeasureDCm-dependentfluorescence, con-
canamycin A-treated parasites were normalized to 100% and the
baseline (0%)was set by FCCPaddition (10 mM). Atovaquoneaddition
rapidly (≈3min) reduced concanamycin-independent TMRE fluores-
cenceby70%(Figures3and4a). Similarly, bothartemisininand tetra-
oxanedecreased the concanamycin-independent TMREfluorescence
by 60% and 50%, respectively (Figures 3 and 4b and c).
Depolarization of the plasma membrane potential
by endoperoxides
TheDCmwasdemonstrated to representbetween20%and30%of
the total cellular TMRE fluorescence, leaving a homogeneous cyto-
solic signal originating fromtheplasmamembraneonly.43 Toevalu-
ate the DCp-dependent fluorescence, parasites were pretreated
with 100 nM atovaquone for 5 min before addition of the endoper-
oxide inhibitor. For these experiments, atovaquone-treated para-
sites were normalized to 100% and the baseline (0%) was set by
Figure 2. Effect of endoperoxide antimalarials on both the plasma and mitochondrial membrane potential of P. falciparum. Time course of
TMRE-dependent fluorescence of P. falciparum-infected erythrocytes after the addition of (a) 100 nM atovaquone, (b) 100 nM deoxyartemisinin,
(c) 100 nM artemisinin, (d) 100 nM tetraoxane (compound RKA182), (e) 100 nM artesunate and (f) 100 nM dihydroartemisinin. The data were normalized
to100%inuntreatedcells and to0% inFCCP (10 mM)-treatedcells. Graphsshowmeans fromexperimentsperformed independently+standarderrors (n≥7).
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FCCP addition (10 mM). The vacuolar H+-ATPase is involved in trans-
forming the energy of ATP hydrolysis to generate the electrochem-
ical potential at the surface of the malaria parasite through the
transport of H+ across the plasmamembrane.51 As expected, the
addition of concanamycinA, awell-knownV-typeATPase inhibitor,
rapidly decreased DCp-dependent fluorescence by 60%
(Figure 5a). In a similar manner, artemisinin and tetraoxane were
observed to decrease the atovaquone-independent fluorescence
signal by 40% and 60%, respectively (Figure 5b and c).
The described data confirm that bothDCm andDCp are rapidly
depolarized upon exposure to physiological concentrations of
endoperoxides. The next set of experiments was performed to
ascertain whether the rapid depolarization would be affected by
chelation of free Fe3+, as previously hypothesized by other studies.
Effect of Fe31 chelators desferrioxamine (DFO) and
deferipone (DFP) on the membrane potential
depolarization by artemisinin and tetraoxane
DFO and DFP, two chelating agents selective for non-haem Fe3+,52
were used at a fixed dose to determine the effect of free iron on
the rapid endoperoxide-induced, parasite total (DCm and DCp)
membrane potential depolarization.
Growth inhibition studies (48 h IC50) using both iron chelators
revealed moderate antimalarial activity against 3D7 P. falciparum
of 17.3+2 mM (DFO) and 111.8+2 mM (DFP). However, during the
short timeperiod of the single-cell assays (,6 min), the additionof
100 mM DFO or 100 mM DFP to the perfusate did not result in a
decrease of parasite DCm and DCp-dependent fluorescence
signal. However, additionofDFOandDFP (100 mM) to theperfusate
was observed to significantly minimize the depolarization caused
by either artemisinin (100 nM; Figure 6a) or tetraoxane (100 nM;
Figure 6b), relative to chelator-free controls. For both endoperox-
ides, DFO was observed to confer greater protection than DFP.
Next, it was investigated whether ROS scavengers would also
confer a protective effect against endoperoxides as postulated in
previous studies.
Effect of the superoxide scavenger Tiron on themembrane
potential depolarization induced by artemisinin and
tetraoxane
Tiron, a cell membrane-permeable superoxide scavenger, was
added (100 mM) to the perfusate and endoperoxide-induced DCm
and DCp depolarization was measured as described previously.
Tiron was clearly observed to have a significant protective effect
against endoperoxide-inducedmembranepotential depolarization,
decreasing the rate of depolarization by.50% for both artemisinin
andtetraoxane(Figure7). Incontrolexperiments, Tironalonehadno
1a 1b 5 mm
5 mm
5 mm
M
M
M
FV
0 s + 300 s
+ 300 s
+ 300 s
0 s
0 s
1c
2a 2b 2c
3a 3b 3c
Figure 3. Effect of atovaquone, artemisinin and tetraoxane (RKA182) on fluorescent mitochondria from P. falciparum trophozoites. Bright-field
fluorescence (a) and TMRE fluorescence images of concanamycin-pretreated infected erythrocytes before induction (b) and 300 s after induction
(c) with 100 nM atovaquone (1), 100 nM artemisinin (2) and 100 nM tetraoxane (3). The green in these images is a pseudocolour. ‘M’ indicates the
parasite mitochondrion and ‘FV’ indicates the food vacuole.
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effect on parasiteDCm andDCp based on TMRE fluorescence (data
not shown).
Discussion
ETC components are not a direct target for endoperoxides
Specific inhibition by endoperoxides has previously been reported
for Plasmodium cytochrome c oxidase (complex IV)37,38 and type
II NADH:quinone oxidoreductase (PfNDH2).16 In agreement with
previous studies, we also noted inhibition of complex IV but only
to a maximum of 20% at relatively high concentrations (1 mM) of
a range of endoperoxides (Table 1). Little or no inhibition was
observed, however, for either recombinant PfNDH2 or bc1
(Table 1). It should be noted that all enzymatic assays were per-
formed using either cell-free extracts or E. coli membrane
preparations and would be expected to have contained trace
Fe2+ and, for the parasite extract, haem. These data indicate that
ETC components are not direct targets for endoperoxide inhibition
in Plasmodium. Previous studies reporting inhibition of PfNDH2 by
endoperoxides16 did not measure the enzyme directly, but rather
showed increasedsensitivity toendoperoxides inyeast transfected
with PfNDH2. It is likely, therefore, that PfNDH2 in the yeast system
increased sensitivity to endoperoxides via an indirect effect, pos-
sibly by serving as a source of ROS by electron transfer from the
PfNDH2 flavin to O2 or potentially directly to the endoperoxides.
Rapid loss of parasite vitality upon exposure
to endoperoxides
In unicellular organisms, life can be defined as the maintenance
of an electrochemical potential across the organism’s outer
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Figure 4. Effect of artemisinin and tetraoxane on mitochondrial membrane potential only. Plasma membrane potential is depolarized by treatment of
P. falciparum-infected erythrocytes with 200 nM concanamycin A before addition of inhibitors. Time course of TMRE-plasma independent fluorescence
is followed after addition of (a) 10 nM atovaquone, (b) 100 nM artemisinin and (c) 100 nM tetraoxane. Data were normalized to 100% in untreated
cells and to 0% in FCCP (10 mM)-treated cells. Graphs showmeans from experiments performed independently+standard errors (n≥7).
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membrane (negative entropy).53 Plasmodia have a proton poten-
tial across theplasmamembrane (DCp)of295 mV.51,54It is gen-
erated by V-type H+-ATPases, which transfer protons out of the
parasite cytosol.55,56 Localized in the plasma membrane, the
V-type H+-ATPase also plays a role in regulating a neutral cytosolic
pH (near 7.3), crucial for enzyme function, incorporation of vitamin
B5 and generation of a pH gradient across membranes of internal
organelles.56,57 The maintenance of a DCp is also important in
mediating the influx of K+ in the parasite cytosol and the uptake
of nutrients such as choline.51,58,59 The direct inhibition of the
V-type H+-ATPase by specific inhibitors such as bafilomycin A1 or
concanamycin A has been demonstrated to depolarize the
plasma membrane potential and disrupt the physiology of the
parasite, leading to its death.43,51,57 The parasite mitochondrial
membrane potential (DCm) is generated via the ETC, through the
activity of the bc1 complex and cytochrome c oxidase.
43,60
An essential function of the mitochondrion for parasite survival
during the intraerythrocytic stages is the provision of orotate for
pyrimidine biosynthesis through the activity of dihydroorotate
dehydrogenase.61,62
Exposure of P. falciparum-infected erythrocytes to pharmaco-
logically relevant concentrations of endoperoxides resulted in a
rapid loss of membrane potential-dependent accumulation of
TMRE (Figure2). Onaccount of the comparatively high contribution
by the DCp (relative tomammalian cells), it was not possible from
these experiments to distinguish whether the depolarization was
on account of an effect on the DCp alone and/or the DCm. Inhib-
itionof theparasiteV-typeH+-ATPasebyadditionof concanamycin
A to the perfusate ‘unmasked’ the parasite to reveal the DCm-
dependent accumulation of TMRE (Figure 3). With this manipula-
tion, it was possible to determine that for all the endoperoxide
classes tested, DCm was rapidly depolarized (Figure 4). These
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Figure 5. Effect of artemisinin and tetraoxane on plasma membrane potential only. Mitochondrial membrane potential is depolarized by treatment of
P. falciparum-infected erythrocytes with 100 nM atovaquone before addition of inhibitors. Time course of TMRE-mitochondrial independent
fluorescence is followed after addition of (a) 200 nM concanamycin A, (b) 100 nM artemisinin and (c) 100 nM tetraoxane. Data were normalized to
100%inuntreatedcellsandto0%inFCCP(10 mM)-treatedcells.Graphsshowmeans fromexperimentsperformed independently+standarderrors (n≥7).
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dataareconsistentwith thefindingsbyWangetal.,17whoreported
depolarization of the membrane potential of isolated parasite
mitochondria by artemisinin following 2 h of incubation. Crespo
et al.41 reported mitochondrial dysfunction following exposure to
artemisinin only after 8 h but not after 4 h, interpreting this as a
downstream effect. We note, however, that the Crespo et al.
studydidnotdistinguish betweenDCp- orDCm-dependent rhoda-
mine accumulation and that a washing step occurred in between
rhodamine staining and microscopy. As rhodamine is a cationic
fluorophore, there isabalancebetweentheconcentrationgradient
of the probe and the total DC according to the Nernst equation:
C¼RT/F ln(Pin/Pout), where R, T, F,Din andDout represent the univer-
sal gas constant, the absolute temperature, the Faraday constant
and the intra- and extracellular probe concentrations, respectively.
The washing step would therefore affect the distribution of the
probe in a time-dependent manner and may account for the
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discord between the data of Crespo et al.41 and those presented
here and byWang et al.17
Pretreatment of parasites with atovaquone in the perfusate
further allowed the measurement of DCp alone. Exposure to
endoperoxides resulted in the rapid depolarization of parasite DCp
(Figure 5). The rapid onset of DCp depolarization exposed to
pharmacologically relevant concentrations of endoperoxides indi-
catesthat this isaprimarypharmacodynamicevent leadingtopara-
site death and is consistent with in vitro63 and in vivo64,65 studies
reporting the rapid killing rate of the endoperoxide class. The rapid
onset of DCp depolarization by endoperoxides is also consistent
with studies demonstrating that short pulses of artemisinins
(1–6 h) are sufficient for parasite kill, albeit with stage-dependent
differences.66,67 It is also noteworthy that disruption of the parasite
transmembrane pH gradient via inhibition of the V-type ATPase
has been reported to drop the cytosolic pH by 0.4 pH units in
,3 min and 0.5–0.6 units within 20 min,56,57 leading to the inhib-
ition of parasite growthwithin 30 min to 4 h (depending on inhibitor
concentration).57
Deoxyartemisinin did not to have any depolarizing effect on
either parasite DCp or DCm (Figure 2). This result is in line with
previous studies17,68,69 and confirms the importance of the endo-
peroxide bond in mediating antimalarial activity.
Rapid depolarization of the parasite DCp involves
iron and ROS
The parasite’s unique ability to digest haemoglobin is generally
accepted to confer selective toxicity to endoperoxides (e.g. Klonis
et al.22) either directly, by activation of the endoperoxides by
Fe2+5 and/or haem,70 or indirectly through the ability of Fe3+ to
oxidize cytosolic (reduced) cofactors.18 In this study, we used
DFO and DFP, two known chelators of Fe3+,71 to determine the
effect on endoperoxide-induced DCp depolarization. Addition of
the chelators to the perfusatewas clearlyobserved to confera pro-
tective effect to the parasite upon exposure to the endoperoxides
(Figure 6). These data can be interpreted to suggest that Fe3+ is
involved in the depolarization of the parasitemembrane. The iron-
mediated hypothesis of endoperoxide activation identifies a role
for Fe2+. As the chelators have amuchhigheraffinity for Fe3+ com-
pared with Fe2+, such a mechanism would necessitate the add-
itional presence of redox cycling activities, such as thiols
GSH↔GSSG (reduced and oxidized glutathione, respectively)
and/or flavin enzymes. In previous experiments performed in situ
using single-cell imaging, we observed that endoperoxide–
acridine adducts could be completely washed out in the presence
ofDFO, but remained irreversibly bound in theabsenceofDFO, sug-
gesting that the drugs were being activated by iron to form stable
covalent adducts.52 It is therefore possible that the protective
effect of the iron chelators observed in our studies here is a result
of adecrease in thebioactivationof theendoperoxides. Analterna-
tive or additional explanation is that the iron chelators conferred a
protective effect by decreasing the generation of ROS through
Fe2+-mediatedoxidative stress suchas the Fenton reaction, gener-
ating the highly membrane damaging hydroxyl radical (·OH). It is
also noteworthy that DFO has been reported to be able to directly
scavenge ROS.72 It should also be noted that in the experiments
presented here, intracellular haem concentrations cannot be se-
lectively and rapidly manipulated; therefore, the potential role of
haemin thedepolarizationofDCpbyendoperoxidescannotbeelu-
cidated.
Although the exact protective mechanism for iron cannot be
deduced from our data, a role for ROS is clearly demonstrated in
experiments using Tiron, the superoxide anion (·O2
2) scavenger,
showing a decreased rate of membrane depolarization following
exposure to endoperoxides (Figure 7). The indiscriminate nature
of the depolarization of bothDCp or DCm is suggestive of amech-
anism involving thegeneral lipidperoxidationof theparasitemem-
branes; however, in addition to this, a specific inhibition of key
enzymes such as the V-type ATPase by ROS cannot be ruled out.73
Conclusions
In summary, this study reports that rapid loss of DCp following
exposure to endoperoxides is a primary physiological event
leading to parasite death. A loss of DCm is also reported, but the
lack of direct inhibition of ETC H+-pumping complexes by endoper-
oxides and the indiscriminate nature of membrane depolarization
is consistentwith anon-ETCmodeof action, as reported recently in
mammaliancells.42 The rapiddepolarizationofDCpbyendoperox-
ides involves ROS and iron, but it is not discernible from this study
whether ironplaysa role in endoperoxidebioactivationand/or iron-
mediated oxidative stress.
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